32 results on '"Bélisle-Pipon JC"'
Search Results
2. Voice as a Biomarker in Health-Tech: Mapping the Evolving Landscape of Voice Biomarkers in the Start-Up World.
- Author
-
Evangelista EG, Bélisle-Pipon JC, Naunheim MR, Powell M, Gallois H, and Bensoussan Y
- Subjects
- Humans, Artificial Intelligence, Biomarkers, Voice physiology
- Abstract
Objective: The vocal biomarkers market was worth $1.9B in 2021 and is projected to exceed $5.1B by 2028, for a compound annual growth rate of 15.15%. The investment growth demonstrates a blossoming interest in voice and artificial intelligence (AI) as it relates to human health. The objective of this study was to map the current landscape of start-ups utilizing voice as a biomarker in health-tech., Data Sources: A comprehensive search for start-ups was conducted using Google, LinkedIn, Twitter, and Facebook. A review of the research was performed using company website, PubMed, and Google Scholar., Review Methods: A 3-pronged approach was taken to thoroughly map the landscape. First, an internet search was conducted to identify current start-ups focusing on products relating to voice as a biomarker of health. Second, Crunchbase was utilized to collect financial and organizational information. Third, a review of the literature was conducted to analyze publications associated with the identified start-ups., Results: A total of 27 start-up start-ups with a focus in the utilization of AI for developing biomarkers of health from the human voice were identified. Twenty-four of these start-ups garnered $178,808,039 in investments. The 27 start-ups published 194 publications combined, 128 (66%) of which were peer reviewed., Conclusion: There is growing enthusiasm surrounding voice as a biomarker in health-tech. Academic drive may complement commercialization to best achieve progress in this arena. More research is needed to accurately capture the entirety of the field, including larger industry players, academic institutions, and non-English content., (© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
3. Stakeholder perspectives on ethical and trustworthy voice AI in health care.
- Author
-
Bélisle-Pipon JC, Powell M, English R, Malo MF, Ravitsky V, and Bensoussan Y
- Abstract
Objective: Voice as a health biomarker using artificial intelligence (AI) is gaining momentum in research. The noninvasiveness of voice data collection through accessible technology (such as smartphones, telehealth, and ambient recordings) or within clinical contexts means voice AI may help address health disparities and promote the inclusion of marginalized communities. However, the development of AI-ready voice datasets free from bias and discrimination is a complex task. The objective of this study is to better understand the perspectives of engaged and interested stakeholders regarding ethical and trustworthy voice AI, to inform both further ethical inquiry and technology innovation., Methods: A questionnaire was administered to voice AI experts, clinicians, scholars, patients, trainees, and policy-makers who participated at the 2023 Voice AI Symposium organized by the Bridge2AI-Voice AI Consortium. The survey used a mix of Likert scale, ranking and open-ended questions. A total of 27 stakeholders participated in the study., Results: The main results of the study are the identification of priorities in terms of ethical issues, an initial definition of ethically sourced data for voice AI, insights into the use of synthetic voice data, and proposals for acting on the trustworthiness of voice AI. The study shows a diversity of perspectives and adds nuance to the planning and development of ethical and trustworthy voice AI., Conclusions: This study represents the first stakeholder survey related to voice as a biomarker of health published to date. This study sheds light on the critical importance of ethics and trustworthiness in the development of voice AI technologies for health applications., Competing Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
4. Cell Maps for Artificial Intelligence: AI-Ready Maps of Human Cell Architecture from Disease-Relevant Cell Lines.
- Author
-
Clark T, Mohan J, Schaffer L, Obernier K, Al Manir S, Churas CP, Dailamy A, Doctor Y, Forget A, Hansen JN, Hu M, Lenkiewicz J, Levinson MA, Marquez C, Nourreddine S, Niestroy J, Pratt D, Qian G, Thaker S, Bélisle-Pipon JC, Brandt C, Chen J, Ding Y, Fodeh S, Krogan N, Lundberg E, Mali P, Payne-Foster P, Ratcliffe S, Ravitsky V, Sali A, Schulz W, and Ideker T
- Abstract
This article describes the Cell Maps for Artificial Intelligence (CM4AI) project and its goals, methods, standards, current datasets, software tools , status, and future directions. CM4AI is the Functional Genomics Data Generation Project in the U.S. National Institute of Health's (NIH) Bridge2AI program. Its overarching mission is to produce ethical, AI-ready datasets of cell architecture, inferred from multimodal data collected for human cell lines, to enable transformative biomedical AI research.
- Published
- 2024
- Full Text
- View/download PDF
5. AI and the falling sky: interrogating X-Risk.
- Author
-
Jecker NS, Atuire CA, Bélisle-Pipon JC, Ravitsky V, and Ho A
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2024
- Full Text
- View/download PDF
6. Bioethics' Duty to Conference in Qatar: Reply to Magnus.
- Author
-
Jecker NS, Savulescu J, Caplan A, Capron A, McMillan J, Ghaly M, Ortiz Millán G, Atuire C, McMahan J, Chuan VT, Bélisle-Pipon JC, Viswani V, and Ravitsky V
- Subjects
- Humans, Qatar, Bioethics
- Published
- 2024
- Full Text
- View/download PDF
7. The Ethics of International Bioethics Conferencing: Continuing the Conversation.
- Author
-
Jecker NS, Atuire C, Ravitsky V, Ghaly M, and Bélisle-Pipon JC
- Subjects
- Humans, Ethicists, Bioethics
- Published
- 2024
- Full Text
- View/download PDF
8. Proposed Principles for International Bioethics Conferencing: Anti-Discriminatory, Global, and Inclusive.
- Author
-
Jecker NS, Ravitsky V, Ghaly M, Bélisle-Pipon JC, and Atuire C
- Subjects
- Humans, Ethicists, Bioethics
- Abstract
This paper opens a critical conversation about the ethics of international bioethics conferencing and proposes principles that commit to being anti-discriminatory, global, and inclusive. We launch this conversation in the Section, Case Study, with a case example involving the International Association of Bioethics' (IAB's) selection of Qatar to host the 2024 World Congress of Bioethics. IAB's choice of Qatar sparked controversy. We believe it also may reveal deeper issues of Islamophobia in bioethics. The Section, Principles for International Bioethics Conferencing, sets forth and defends proposed principles for international bioethics conferencing. The Section, Applying Principles to Site Selection applies the proposed principles to the case example. The Section, Applying Principles Beyond Site Selection addresses other applications of the proposed principles. The Section, Objections responds to objections. We close (in the Section, Conclusion) by calling for a wider discussion of our proposed principles. One-Sentence Capsule Summary: How should bioethicists navigate the ethics of global bioethics conferencing?
- Published
- 2024
- Full Text
- View/download PDF
9. Understanding drug exceptional access programs (DEAPs) in Canada, and their associated social and political issues.
- Author
-
David PM, Lata KL, Bouthillier ME, and Bélisle-Pipon JC
- Subjects
- Humans, Canada, Health Services Accessibility, Pharmaceutical Preparations supply & distribution
- Abstract
Drug exceptional access programs (DEAPs) exist across Canada to address gaps in access to pharmaceuticals. These programs circumvent standard procedures, raising epistemic, economic, social and political issues. This commentary provides insights into these issues by revealing the context and procedures on which these programs depend., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
10. Alternative cancer clinics' use of Google listings and reviews to mislead potential patients.
- Author
-
Zenone M, Snyder J, van Schalkwyk M, Bélisle-Pipon JC, Hartwell G, Caulfield T, and Maani N
- Abstract
Background: Alternative cancer clinics, who provide treatment associated with earlier time to death, actively seek to create favorable views of their services online. An unexplored means where alternative cancer clinics can shape their appeal is their Google search results., Methods: We retrieved the Google listing and Google reviews of 47 prominent alternative cancer clinics on August 22, 2022. We then conducted a content analysis to assess the information cancer patients are faced with online., Results: Google listings of alternative treatment providers rarely declared the clinic was an alternative clinic versus a conventional primary cancer treatment provider (12.8% declared; 83.0% undeclared). The clinics were highly rated (median, 4.5 stars of 5). Reasons for positive reviews included treatment quality ( n = 519), care ( n = 420), and outcomes ( n = 316). 288 reviews presented the clinics to cure or improve cancer. Negative reviews presented alternative clinics to financially exploit patients with ineffective treatment ( n = 98), worsen patients' condition ( n = 72), provide poor care ( n = 41), and misrepresent outcomes ( n = 23)., Conclusions: The favorable Google listing and reviews of alternative clinics contribute to harmful online ecosystems. Reviews provide compelling narratives but are an ineffective indicator of treatment outcomes. Google lacks safeguards for truthful reviews and should not be used for medical decision-making., Competing Interests: Competing interestsThe authors declare no competing interests., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
11. Your robot therapist is not your therapist: understanding the role of AI-powered mental health chatbots.
- Author
-
Khawaja Z and Bélisle-Pipon JC
- Abstract
Artificial intelligence (AI)-powered chatbots have the potential to substantially increase access to affordable and effective mental health services by supplementing the work of clinicians. Their 24/7 availability and accessibility through a mobile phone allow individuals to obtain help whenever and wherever needed, overcoming financial and logistical barriers. Although psychological AI chatbots have the ability to make significant improvements in providing mental health care services, they do not come without ethical and technical challenges. Some major concerns include providing inadequate or harmful support, exploiting vulnerable populations, and potentially producing discriminatory advice due to algorithmic bias. However, it is not always obvious for users to fully understand the nature of the relationship they have with chatbots. There can be significant misunderstandings about the exact purpose of the chatbot, particularly in terms of care expectations, ability to adapt to the particularities of users and responsiveness in terms of the needs and resources/treatments that can be offered. Hence, it is imperative that users are aware of the limited therapeutic relationship they can enjoy when interacting with mental health chatbots. Ignorance or misunderstanding of such limitations or of the role of psychological AI chatbots may lead to a therapeutic misconception (TM) where the user would underestimate the restrictions of such technologies and overestimate their ability to provide actual therapeutic support and guidance. TM raises major ethical concerns that can exacerbate one's mental health contributing to the global mental health crisis. This paper will explore the various ways in which TM can occur particularly through inaccurate marketing of these chatbots, forming a digital therapeutic alliance with them, receiving harmful advice due to bias in the design and algorithm, and the chatbots inability to foster autonomy with patients., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2023 Khawaja and Bélisle-Pipon.)
- Published
- 2023
- Full Text
- View/download PDF
12. Generative AI, Specific Moral Values: A Closer Look at ChatGPT's New Ethical Implications for Medical AI.
- Author
-
Victor G, Bélisle-Pipon JC, and Ravitsky V
- Published
- 2023
- Full Text
- View/download PDF
13. Investigating the Influence of Artificial Intelligence on Adolescent Health: An Urgent Call to Action.
- Author
-
Brisson J, Bélisle-Pipon JC, and Ravitsky V
- Subjects
- Adolescent, Humans, Adolescent Health, Artificial Intelligence
- Published
- 2023
- Full Text
- View/download PDF
14. Individuals and (Synthetic) Data Points: Using Value-Sensitive Design to Foster Ethical Deliberations on Epistemic Transitions.
- Author
-
Bélisle-Pipon JC, Ravitsky V, and Bensoussan Y
- Published
- 2023
- Full Text
- View/download PDF
15. Specific challenges posed by artificial intelligence in research ethics.
- Author
-
Bouhouita-Guermech S, Gogognon P, and Bélisle-Pipon JC
- Abstract
Background: The twenty first century is often defined as the era of Artificial Intelligence (AI), which raises many questions regarding its impact on society. It is already significantly changing many practices in different fields. Research ethics (RE) is no exception. Many challenges, including responsibility, privacy, and transparency, are encountered. Research ethics boards (REB) have been established to ensure that ethical practices are adequately followed during research projects. This scoping review aims to bring out the challenges of AI in research ethics and to investigate if REBs are equipped to evaluate them., Methods: Three electronic databases were selected to collect peer-reviewed articles that fit the inclusion criteria (English or French, published between 2016 and 2021, containing AI, RE, and REB). Two instigators independently reviewed each piece by screening with Covidence and then coding with NVivo., Results: From having a total of 657 articles to review, we were left with a final sample of 28 relevant papers for our scoping review. The selected literature described AI in research ethics (i.e., views on current guidelines, key ethical concept and approaches, key issues of the current state of AI-specific RE guidelines) and REBs regarding AI (i.e., their roles, scope and approaches, key practices and processes, limitations and challenges, stakeholder perceptions). However, the literature often described REBs ethical assessment practices of projects in AI research as lacking knowledge and tools., Conclusion: Ethical reflections are taking a step forward while normative guidelines adaptation to AI's reality is still dawdling. This impacts REBs and most stakeholders involved with AI. Indeed, REBs are not equipped enough to adequately evaluate AI research ethics and require standard guidelines to help them do so., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Bouhouita-Guermech, Gogognon and Bélisle-Pipon.)
- Published
- 2023
- Full Text
- View/download PDF
16. Advertising Alternative Cancer Treatments and Approaches on Meta Social Media Platforms: Content Analysis.
- Author
-
Zenone M, Snyder J, Bélisle-Pipon JC, Caulfield T, van Schalkwyk M, and Maani N
- Abstract
Background: Alternative cancer treatment is associated with a greater risk of death than cancer patients undergoing conventional treatments. Anecdotal evidence suggests cancer patients view paid advertisements promoting alternative cancer treatment on social media, but the extent and nature of this advertising remain unknown. This context suggests an urgent need to investigate alternative cancer treatment advertising on social media., Objective: This study aimed to systematically analyze the advertising activities of prominent alternative cancer treatment practitioners on Meta platforms, including Facebook, Instagram, Messenger, and Audience Network. We specifically sought to determine (1) whether paid advertising for alternative cancer treatment occurs on Meta social media platforms, (2) the strategies and messages of alternative cancer providers to reach and appeal to prospective patients, and (3) how the efficacy of alternative treatments is portrayed., Methods: Between December 6, 2021, and December 12, 2021, we collected active advertisements from alternative cancer clinics using the Meta Ad Library. The information collected included identification number, URL, active/inactive status, dates launched/ran, advertiser page name, and a screenshot (image) or recording (video) of the advertisement. We then conducted a content analysis to determine how alternative cancer providers communicate the claimed benefits of their services and evaluated how they portrayed alternative cancer treatment efficacy., Results: We identified 310 paid advertisements from 11 alternative cancer clinics on Meta (Facebook, Instagram, or Messenger) marketing alternative treatment approaches, care, and interventions. Alternative cancer providers appealed to prospective patients through eight strategies: (1) advertiser representation as a legitimate medical provider (n=289, 93.2%); (2) appealing to persons with limited treatments options (n=203, 65.5%); (3) client testimonials (n=168, 54.2%); (4) promoting holistic approaches (n=121, 39%); (5) promoting messages of care (n=81, 26.1%); (6) rhetoric related to science and research (n=72, 23.2%); (7) rhetoric pertaining to the latest technology (n=63, 20.3%); and (8) focusing treatment on cancer origins and cause (n=43, 13.9%). Overall, 25.8% (n=80) of advertisements included a direct statement claiming provider treatment can cure cancer or prolong life., Conclusions: Our results provide evidence alternative cancer providers are using Meta advertising products to market scientifically unsupported cancer treatments. Advertisements regularly referenced "alternative" and "natural" treatment approaches to cancer. Imagery and text content that emulated evidence-based medical providers created the impression that the offered treatments were effective medical options for cancer. Advertisements exploited the hope of patients with terminal and poor prognoses by sharing testimonials of past patients who allegedly were cured or had their lives prolonged. We recommend that Meta introduce a mandatory, human-led authorization process that is not reliant upon artificial intelligence for medical-related advertisers before giving advertising permissions. Further research should focus on the conflict of interest between social media platforms advertising products and public health., (©Marco Zenone, Jeremy Snyder, Jean-Christophe Bélisle-Pipon, Timothy Caulfield, May van Schalkwyk, Nason Maani. Originally published in JMIR Infodemiology (https://infodemiology.jmir.org), 31.05.2023.)
- Published
- 2023
- Full Text
- View/download PDF
17. Ethical Implications of Artificial Intelligence in Population Health and the Public's Role in Its Governance: Perspectives From a Citizen and Expert Panel.
- Author
-
Couture V, Roy MC, Dez E, Laperle S, and Bélisle-Pipon JC
- Subjects
- Humans, Consensus, Population Health, Artificial Intelligence ethics
- Abstract
Background: Artificial intelligence (AI) systems are widely used in the health care sector. Mainly applied for individualized care, AI is increasingly aimed at population health. This raises important ethical considerations but also calls for responsible governance, considering that this will affect the population. However, the literature points to a lack of citizen participation in the governance of AI in health. Therefore, it is necessary to investigate the governance of the ethical and societal implications of AI in population health., Objective: This study aimed to explore the perspectives and attitudes of citizens and experts regarding the ethics of AI in population health, the engagement of citizens in AI governance, and the potential of a digital app to foster citizen engagement., Methods: We recruited a panel of 21 citizens and experts. Using a web-based survey, we explored their perspectives and attitudes on the ethical issues of AI in population health, the relative role of citizens and other actors in AI governance, and the ways in which citizens can be supported to participate in AI governance through a digital app. The responses of the participants were analyzed quantitatively and qualitatively., Results: According to the participants, AI is perceived to be already present in population health and its benefits are regarded positively, but there is a consensus that AI has substantial societal implications. The participants also showed a high level of agreement toward involving citizens into AI governance. They highlighted the aspects to be considered in the creation of a digital app to foster this involvement. They recognized the importance of creating an app that is both accessible and transparent., Conclusions: These results offer avenues for the development of a digital app to raise awareness, to survey, and to support citizens' decision-making regarding the ethical, legal, and social issues of AI in population health., (©Vincent Couture, Marie-Christine Roy, Emma Dez, Samuel Laperle, Jean-Christophe Bélisle-Pipon. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.04.2023.)
- Published
- 2023
- Full Text
- View/download PDF
18. Digital Therapies (DTx) as New Tools within Physicians' Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use.
- Author
-
Bélisle-Pipon JC and David PM
- Subjects
- Humans, Therapy, Computer-Assisted
- Abstract
In recent years, there has been a swift rise in the development of digital therapies (DTx). As a result of various technological advances and accessibility to patients, it is now possible to develop and offer therapeutic interventions in a digital manner. These take the form of an evidence-based intervention that is administered in digital form to prevent, manage, or treat a medical condition. What makes DTx significantly different from other types of digital applications or services (e.g., wellness applications) is that they are interventions authorised by regulatory agencies for the treatment, like a drug, of a health condition. Yielding actual therapeutic benefits and being at the crossroads of health and digital means that DTx are subject to both the upsides and downsides of both sectors. Thus, it is of particular interest to look at the facilitators and barriers to be foreseen in the development, assessment, and implementation of DTx. In this article, we will present key observations and outline the main challenges that may be faced in the development and integration of DTx into practice. It is certain that DTx can represent an interesting avenue for physicians to bring their prescribing role into the 21st century. We conclude with broad lessons that the emerging field of DTx can learn from decades of drug industry practice to avoid history repeating itself and to fast-track the development and ethical and optimal use of DTx., (© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2023
- Full Text
- View/download PDF
19. What Makes Artificial Intelligence Exceptional in Health Technology Assessment?
- Author
-
Bélisle-Pipon JC, Couture V, Roy MC, Ganache I, Goetghebeur M, and Cohen IG
- Abstract
The application of artificial intelligence (AI) may revolutionize the healthcare system, leading to enhance efficiency by automatizing routine tasks and decreasing health-related costs, broadening access to healthcare delivery, targeting more precisely patient needs, and assisting clinicians in their decision-making. For these benefits to materialize, governments and health authorities must regulate AI, and conduct appropriate health technology assessment (HTA). Many authors have highlighted that AI health technologies (AIHT) challenge traditional evaluation and regulatory processes. To inform and support HTA organizations and regulators in adapting their processes to AIHTs, we conducted a systematic review of the literature on the challenges posed by AIHTs in HTA and health regulation. Our research question was: What makes artificial intelligence exceptional in HTA? The current body of literature appears to portray AIHTs as being exceptional to HTA. This exceptionalism is expressed along 5 dimensions: 1) AIHT's distinctive features; 2) their systemic impacts on health care and the health sector; 3) the increased expectations towards AI in health; 4) the new ethical, social and legal challenges that arise from deploying AI in the health sector; and 5) the new evaluative constraints that AI poses to HTA. Thus, AIHTs are perceived as exceptional because of their technological characteristics and potential impacts on society at large. As AI implementation by governments and health organizations carries risks of generating new, and amplifying existing, challenges, there are strong arguments for taking into consideration the exceptional aspects of AIHTs, especially as their impacts on the healthcare system will be far greater than that of drugs and medical devices. As AIHTs begin to be increasingly introduced into the health care sector, there is a window of opportunity for HTA agencies and scholars to consider AIHTs' exceptionalism and to work towards only deploying clinically, economically, socially acceptable AIHTs in the health care system., Competing Interests: IGC serves as a bioethics consultant for Otsuka on their Abilify MyCite product, is a member of the Illumina ethics advisory Board, and serves as an ethics consultant for Dawnlight. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Bélisle-Pipon, Couture, Roy, Ganache, Goetghebeur and Cohen.)
- Published
- 2021
- Full Text
- View/download PDF
20. Chapitre 4. How Artistic Transgressive Posture May Challenge Research Ethics Norms.
- Author
-
Voarino N and Bélisle-Pipon JC
- Abstract
Research-creation (RC), an emergent field at the interface of academic research and creative activities, is challenging norms of responsible conduct of research (RCR) as well as research ethics. Striking differences exist between the perspectives of RC practitioners and members of the ethics community. For example, some RC practitioners openly state that they do not care about ethics and RCR regulations, their rationale being that the aim of arts is to transgress rules and so they disagree with having to comply to ethics requirements. Such statements are particularly interesting from a bioethical standpoint and represent a starting point for exploring how RCR can or should apply to RC practices. Using examples stemming from bio art, our aim here is to unravel this apparently conflictual relationship, and to show that it is not necessarily contradictory. We seek to find common grounds and to disarm eventual critiques from both sides when it comes to promoting responsibility in RC.
- Published
- 2020
- Full Text
- View/download PDF
21. Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries.
- Author
-
Bélisle-Pipon JC, Vayena E, Green RC, and Cohen IG
- Subjects
- Humans, United States, Biomedical Research, Genetic Testing, Insurance Coverage, Precision Medicine
- Abstract
While genetic testing may be the gateway to the future of medicine, it also poses challenges for individuals, especially in terms of differentiated treatments on the basis of their genetic characteristics. The fear of unwanted disclosure to insurers and the possibility of genetic discrimination can hamper the recruitment of individuals for clinical research that involves genetic testing. Precision medicine initiatives, such as All of Us, are proliferating in the United States. In order to succeed, however, they must ensure that the millions of Americans recruited to share their genetic data are not penalized with regard to life, disability and long-term insurance coverage. In this Perspective, we discuss several initiatives adopted by countries around the world, such as the United Kingdom and France, that better balance the interests of insurers and research subjects, and explain how the United States might learn from them. We call for regulatory and industry leadership to come together to establish a voluntary moratorium on insurance pricing with the aim of protecting research participants.
- Published
- 2019
- Full Text
- View/download PDF
22. Mapping responsible conduct in the uncharted field of research-creation: A scoping review.
- Author
-
Voarino N, Couture V, Mathieu-Chartier S, Bélisle-Pipon JC, St-Hilaire E, Williams-Jones B, Lapointe FJ, Noury C, Cloutier M, and Gauthier P
- Subjects
- Research Design, Scientific Misconduct
- Abstract
This scoping review addresses the issues of responsible conduct of research (RCR) that can arise in the practice of research-creation (RC), an emergent, interdisciplinary, and heterogeneous field at the interface of academic research and creative activities. Little is yet known about the nature and scope of RCR issues in RC, so our study examined three questions: (1) What are the specific issues in RC in relation to RCR? (2) How does the specificity of RC influence the understanding and practice of RCR? (3) What recommendations could help address the issues highlighted in the literature? To answer these questions, we conducted a scoping review of the academic literature ( n = 181 texts) dealing with RCR in RC. We found that researcher-creators faced some very different RCR challenges in comparison with their colleagues in the rest of academia. Addressing these issues is important for both the RCR and RC communities in order to ensure that the rapid development of this field occurs in line with the norms of RCR which, nonetheless, should be adapted to respect the particularities of RC and allow its contributions to the academic world.
- Published
- 2019
- Full Text
- View/download PDF
23. Patients as research partners; how to value their perceptions, contribution and labor?
- Author
-
Smith E, Bélisle-Pipon JC, and Resnik D
- Abstract
Citizen Science refers to the consultation, participation, engagement or involvement of the general public in research. Rationales for this interaction include increased public access and involvement of citizens in research, immersion of community values relevant to research, outreach and educational potential with the public, and ultimately, the democratization of science. This paper focuses on the specific subset of citizen science that seeks to engage "patient partners" in health research to gain the valuable experiential knowledge of those living with a disease. Greater patient engagement in research (PER) can provide researchers with insights about citizen values and needs relevant to determining research priorities, methodology, applications and ethical parameters; this would ideally lead to more effective real-world applications. Over the last decade, projects involving patients partners in research (PPR) have varied from mere tokenism and undervaluation to full involvement and empowerment of patient participants - the former, a subject of criticism, and the latter, promoted as an ideal. In this article, we will argue that the value of that experiential knowledge from patient partners in research should not only be acknowledged through its ongoing use, but also through recognition of participants who contribute to the creation and application of new knowledge. We will explore types of recognition that might be attributed to PPR, including scientific recognition; financial recognition or reward; personal and altruistic recognition; and the benefial outcomes of research applications. We will also consider whether such types of recognition could be applied to the broader field of citizen science., Competing Interests: Competing Interest The authors have no competing interests to declare.
- Published
- 2019
- Full Text
- View/download PDF
24. Full Collection of Personal Narratives.
- Author
-
Soutar IF, Bear M, Savoie H, Farmer L, Bélisle-Pipon JC, Grande CD, Rouleau G, Thiagarajan S, Wacha S, Lee AM, Bressler DW, Jackson JK, Ehrhart MJ, Arscott DB, Nguyen KA, Michelucci P, Hastings JJ, Nichols M, Nuñez-Farias P, Velásquez-Contreras S, Ríos-Carmona V, Velásquez-Contreras J, Velásquez-Contreras AE, Rojas-Rojas JL, Riveros-Flores B, Hulbert J, and Santos-Lang C
- Published
- 2019
- Full Text
- View/download PDF
25. "Engage Patients in Your Research," They Say.
- Author
-
Bélisle-Pipon JC, Grande CD, and Rouleau G
- Subjects
- Ethics, Nursing, Evidence-Based Nursing, Humans, Life Change Events, Narration, Nursing Research ethics, Research Personnel, Nursing Research organization & administration, Patient Participation
- Published
- 2019
- Full Text
- View/download PDF
26. Conflicts of interest and the (in)dependence of experts advising government on immunization policies.
- Author
-
Bélisle-Pipon JC, Ringuette L, Cloutier AI, Doudenkova V, and Williams-Jones B
- Subjects
- Advisory Committees economics, Health Policy, Quebec, Conflict of Interest economics, Government, Immunization legislation & jurisprudence, Policy Making
- Abstract
There has been increasing attention to financial conflicts of interest (COI) in public health research and policy making, with concerns that some decisions are not in the public interest. One notable problematic area is expert advisory committee (EAC). While COI management has focused on disclosure, it could go further and assess experts' degree of (in)dependence with commercial interests. We analyzed COI disclosures of members of Québec's immunization EAC (in Canada) using (In)DepScale, a tool we developed for assessing experts' level of (in)dependence. We found great variability of independence with industry and that companies with the highest vaccine sales were predominantly associated with disclosed COIs. We argue that EACs can use the (In)DepScale to better assess and disclose the COIs that affect their experts. Going forward our scale could help manage risk and select members who are less conflicted to foster a culture of transparency and trust in advisors and policy-makers., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. Early-career researchers' views on ethical dimensions of patient engagement in research.
- Author
-
Bélisle-Pipon JC, Rouleau G, and Birko S
- Subjects
- Adult, Canada, Ethics, Research, Female, Humans, Male, Professional Competence, Quebec, Research Subjects, Surveys and Questionnaires, Attitude of Health Personnel, Bioethical Issues, Biomedical Research ethics, Patient Participation, Research Design, Research Personnel
- Abstract
Background: Increasing attention and efforts are being put towards engaging patients in health research, and some have even argued that patient engagement in research (PER) is an ethical imperative. Yet there is relatively little empirical data on ethical issues associated with PER., Methods: A three-round Delphi survey was conducted with a panel of early-career researchers (ECRs) involved in PER. One of the objectives was to examine the ethical dimensions of PER as well as ECRs' self-perceived level of preparedness to conduct PER ethically. The study was conducted among awardees of the Québec SPOR-SUPPORT Unit in Canada, who represent the next generation of researchers involved in PER. Many themes were addressed throughout the study, such as definition, values, patients' roles, expected characteristics of patients, and anticipated challenges (including ethical issues). Open-ended questions were used, and all quantitative data were collected through statements using 7-point Likert scales., Results: Between April and November 2016, 25 ECRs were invited to participate; 18 completed both the first and second rounds, and 16 completed the third round. Panelists consisted of nine women and seven men with various backgrounds (general practitioners and postgraduate students). The majority were between 25 and 44 years old. Panelists' responses showed PER raises important ethical issues: 1) professionalization of patients involved in research (with risks of patients becoming less representative); 2) adequate remuneration of patients; 3) fair recognition of patients' experiential knowledge; and 4) tokenism (engaging patients only for symbolic appeal). While the panelists felt moderately prepared to confront these ethical issues, they reported being uncomfortable applying for an ethics certificate for a PER project., Conclusion: If PER is an ethical imperative, it is vital to establish clear ethical standards and to train and support the PER community to identify and resolve ethical issues. Despite their overall readiness to conduct PER, panelists did not feel adequately prepared to address many of these issues. It is not easy for ECRs to reconcile ethical desiderata and logistical imperatives. Additional research should focus on supporting the responsible conduct of PER, which, if not done, can undermine the credibility and feasibility of the entire PER enterprise.
- Published
- 2018
- Full Text
- View/download PDF
28. Merging arts and bioethics: An interdisciplinary experiment in cultural and scientific mediation.
- Author
-
Couture V, Bélisle-Pipon JC, Cloutier M, and Barnabé C
- Subjects
- Canada, Culture, Ethicists, Humans, Art, Bioethical Issues, Bioethics, Interdisciplinary Communication
- Abstract
How to engage the public in a reflection on the most pressing ethical issues of our time? What if part of the solution lies in adopting an interdisciplinary and collaborative strategy to shed light on critical issues in bioethics? An example is Art + Bioéthique, an innovative project that brought together bioethicists, art historians and artists with the aim of expressing bioethics through arts in order to convey the "sensitive" aspect of many health ethics issues. The aim of this project was threefold: 1) to identify and characterize mechanisms for the meeting of arts and bioethics; 2) to experiment with and co-construct a dialogue between arts and bioethics; and 3) to initiate a public discussion on bioethical issues through the blending of arts and bioethics. In connection with an exhibition held in March 2016 at the Espace Projet, a non-profit art space in Montréal (Canada), the project developed a platform that combined artworks, essays and cultural & scientific mediation activities related to the work of six duos of young bioethics researchers and emerging artists. Each duo worked on a variety of issues, such as the social inclusion of disabled people, the challenges of practical applications of nanomedicine and regenerative medicine, and a holistic approach to contemporary diseases. This project, which succeeded in stimulating an interdisciplinary dialogue and collaboration between bioethics and arts, is an example of an innovative approach to knowledge transfer that can move bioethics reflection into the public space., (© 2017 John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
29. An Experiment with Public-Oriented Knowledge Transfer: A Video on Quebec's Bill 10.
- Author
-
Bélisle Pipon JC, Lemoine MÈ, and Laliberté M
- Subjects
- Humans, Public Opinion, Quebec, Social Media, Translational Research, Biomedical legislation & jurisprudence, Health Education methods, Translational Research, Biomedical methods, Video Recording
- Abstract
When decision-makers are engaged in a polarized discourse and leaving aside evidence-based recommendations, is there a role for researchers in the dissemination of this scientific evidence to the general public as a means to counterbalance the debate? In response to the controversial Bill 10 in Quebec, we developed and posted a knowledge transfer video on YouTube to help stimulate critical public debate. This article explains our approach and methodology, and the impact of the video, which, in the space of two weeks, had more than 9,500 views, demonstrating the pertinence of such initiatives. We conclude with recommendations for other research groups to engage in public debates., (Copyright © 2016 Longwoods Publishing.)
- Published
- 2016
30. Duty to Inform and Informed Consent in Diagnostic Radiology: How Ethics and Law can Better Guide Practice.
- Author
-
Doudenkova V and Bélisle Pipon JC
- Subjects
- Canada, Radiation Dosage, Radiation Protection, Informed Consent legislation & jurisprudence, Professional-Patient Relations ethics, Radiography ethics
- Abstract
Although there is consensus on the fact that ionizing radiation used in radiological examinations can affect health, the stochastic (random) nature of risk makes it difficult to anticipate and assess specific health implications for patients. The issue of radiation protection is peculiar as any dosage received in life is cumulative, the sensitivity to radiation is highly variable from one person to another, and between 20 % and 50 % of radiological examinations appear not to be necessary. In this context, one might reasonably assume that information and patient consent would play an important role in regulating radiological practice. However, there is to date no clear consensus regarding the nature and content of-or even need for-consent by patients exposed to ionizing radiation. While law and ethics support the same principles for respecting the dignity of the person (inviolability and integrity), in the context of radiology practice, they do not provide a consistent message to guide clinical decision-making. This article analyzes the issue of healthcare professionals' duty to inform and obtain patient consent for radiological examinations. Considering that both law and ethics have as one of their aims to protect vulnerable populations, it is important that they begin to give greater attention to issues raised by the use of ionizing radiation in medicine. While the situation in Canada serves as a backdrop for a reflective analysis of the problem, the conclusions are pertinent for professional practice in other jurisdictions because the principles underlying health law and jurisprudence are fairly general.
- Published
- 2016
- Full Text
- View/download PDF
31. Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information.
- Author
-
Bélisle-Pipon JC and Williams-Jones B
- Subjects
- Canada, Direct-to-Consumer Advertising legislation & jurisprudence, Drug Industry legislation & jurisprudence, Humans, Information Dissemination legislation & jurisprudence, Prescriptions, Direct-to-Consumer Advertising ethics, Drug Industry ethics, Government Regulation, Information Dissemination ethics, Therapeutic Misconception
- Abstract
Promotion of prescription drugs may appear to be severely limited in some jurisdictions due to restrictions on direct-to-consumer advertising (DTCA). However, in most jurisdictions, strategies exist to raise consumer awareness about prescription drugs, notably through the deployment of direct-to-consumer information (DTCI) campaigns that encourage patients to seek help for particular medical conditions. In Canada, DTCI is presented by industry and regulated by Health Canada as being purely informational activities, but their design and integration in broader promotional campaigns raise very similar ethical concerns as those associated with DTCA. Specifically, DTCI can be an effective means of familiarizing the public with the scope and benefits of a particular prescription drug and so, like DTCA, can promote increased patient-consumer demand and thus a problematic rise in the prescribing and use of medications that may be neither the most appropriate nor the most cost-effective. Yet, with DTCI the industry is playing within the existing rules and regulations set by health regulators. To respond appropriately to this regulatory incoherence, we argue that DTCI should be regulated as a type of direct-to-consumer indirect advertising. Even if the case and specific regulations presented here are Canadian, the implications extend to every country that has a partial or total prohibition on DTCA.
- Published
- 2015
- Full Text
- View/download PDF
32. Mandatory influenza vaccination: how far to go and whom to target without evidence?
- Author
-
Bélisle Pipon JC and Frenette M
- Subjects
- Humans, Cross Infection prevention & control, Health Personnel, Influenza Vaccines administration & dosage, Influenza, Human prevention & control, Mandatory Programs ethics, Mandatory Programs legislation & jurisprudence, Mass Vaccination ethics, Mass Vaccination legislation & jurisprudence, Public Health ethics, Vulnerable Populations
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.